Hong‐Hong Yan

7.4k citations
133 papers · 3.7k indexed · 2 hit papers · h-index 31

Impact in

  • Oncology top 1%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
    • Brain Metastases and Treatment

Papers in

    • Lung Cancer Treatments and Mutations 98
    • Lung Cancer Diagnosis and Treatment 41
    • Lung Cancer Research Studies 38
    • Colorectal Cancer Treatments and Studies 22
    • Cancer Immunotherapy and Biomarkers 12

Hong‐Hong Yan

125 papers receiving 3.7k citations

Hit Papers

Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study 2023 · 110 citations
1102016202620192022200400600

Peers

Hong‐Hong Yan
Comparison fields: 5 of 95
  • Oncology 2.5k
  • Pulmonary and Respiratory Medicine 2.8k
  • Cancer Research 866
  • Hepatology 108
  • Molecular Biology 870
Replace Venice Archer with:
Venice Archer United Kingdom
Radj Gervais France
Chong‐Rui Xu China
Tiziana Usari Italy
Biagio Ricciuti United States
Sarayut Lucien Geater Thailand
Oleg Gladkov Russia
Lorinda Simms United States
Shuichi Hironaka Japan
Conor Steuer United States
Hong‐Hong Yan relative to Venice Archer United Kingdom Venice Archer's profile →
Citations per field
00.5×1.5×2.4×
Venice Archer · 1×
Citations per year

Countries citing papers authored by Hong‐Hong Yan

Since Specialization
Citations

This map shows the geographic impact of Hong‐Hong Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Hong Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Hong Yan more than expected).

Fields of papers citing papers by Hong‐Hong Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong‐Hong Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Hong Yan. The network helps show where Hong‐Hong Yan may publish in the future.

Co-authors

The 25 scholars most cited alongside Hong‐Hong Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hong‐Hong Yan Line = papers co-authored together Hong‐Hong Yan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20242
4 20231
5 202323
6 202318
7 20233
8 20235
9 202211
10 20224
11 2020113
12 20191
13 201916
14 201842
15 20171
16
Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
Hit paper breakdown →
2016741
17 2016211
18 201413
19 201214
20 201117

About Hong‐Hong Yan

Hong‐Hong Yan is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Hepatology and Radiology, Nuclear Medicine and Imaging, having authored 133 papers that have together received 3.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (98 papers), Lung Cancer Diagnosis and Treatment (41 papers), Lung Cancer Research Studies (38 papers), Cancer Genomics and Diagnostics (23 papers), Colorectal Cancer Treatments and Studies (22 papers), Radiomics and Machine Learning in Medical Imaging (15 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers). The work is most often cited by research in Oncology (2.5k citations), Pulmonary and Respiratory Medicine (2.8k citations), Cancer Research (866 citations), Hepatology (108 citations) and Molecular Biology (870 citations). Hong‐Hong Yan has collaborated with scholars based in China, United States and India. Frequent co-authors include Yi‐Long Wu, Jin‐Ji Yang, Qing Zhou, Wen‐Zhao Zhong, Jian Su, Xu‐Chao Zhang, Hai‐Yan Tu, Xue‐Ning Yang, Hua‐Jun Chen and Chong‐Rui Xu. Their work appears in journals such as Journal of Thoracic Oncology, Journal of Clinical Oncology, Lung Cancer, Annals of Oncology and Clinical Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026